Results 221 to 230 of about 22,470,738 (286)

Bilateral primary adrenal lymphoma presenting with chylothorax: imaging findings and diagnostic challenges. [PDF]

BJR Case Rep
Oner UT, Erkoc N, Atay M.
europepmc   +1 more source

The different face of skin‐rash induced by brentuximab vedotin

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri, Tullio Brunetti, Serena Rupoli, Gianluca Cafasso, Corrado Zengarini, Staphano Cedirian, Federico Bardazzi, Cosimo Misciali, Michela Starace, Claudio Agostinelli, Gaia Goteri, Erika Morsia   +11 more
wiley   +1 more source

Case Report: Diffuse large B-cell lymphoma presenting predominantly with spinal cord involvement: a series of three cases confirmed by abdominopelvic lymph node biopsy. [PDF]

Front Neurosci
Zhu Y, Liu H, Zhou ZH, Liu AJ, Xia M.
europepmc   +1 more source

Clinical Characteristics and Prognostic Factors of Primary Bone Diffuse Large B-Cell Lymphoma: A Retrospective Study. [PDF]

Cancer Med
Hou Z, Chen K, Lu Y, Ma X, Zhang S, Cao J, Zhang Q, Liu Y.   +7 more
europepmc   +1 more source

Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis

European Journal of Haematology, EarlyView.
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley   +1 more source

Follicular Lymphoma Arising in an Ileal Neobladder Presenting as a Large Pelvic Mass. [PDF]

IJU Case Rep
Fujita K, Nishino T, Shimbo M, Yamanaka S, Oguchi T, Narimoto K, Hattori K, Kanomata N, Mori S, Endo F.   +9 more
europepmc   +1 more source

Epithelioid Fibrous Histiocytoma With Bulbous Subcutaneous Extension and SQSTM1::ALK Fusion

Journal of Cutaneous Pathology, EarlyView.
Hannah Moorman, Jennifer Crimmins, Joseph Gillam, Scott Turner, Mark C. Mochel   +4 more
wiley   +1 more source

Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non‐Hodgkin Lymphoma on Reproduction Patterns

European Journal of Haematology, EarlyView.
ABSTRACT Concerns about treatment‐related fertility impairment are common among young adult lymphoma survivors. Evidence on the impact of treatment for aggressive non‐Hodgkin lymphoma (NHL) on future childbearing is limited, although many individuals of reproductive age are affected.
Stefanie Antonilli, Anna Marklund, Joshua Entrop, Caroline E. Dietrich, Ingrid Glimelius, Tarec C. El‐Galaly, Alexander Fosså, Harald Holte, Karin E. Smedby, Knut B. Smeland, Sandra Eloranta   +10 more
wiley   +1 more source

Vitreoretinal lymphoma revealing Richter transformation. [PDF]

Am J Ophthalmol Case Rep
Prabha D, Raval V, Mishra D.
europepmc   +1 more source

A Reassessment of the Validity of the Routine Lymph2Cx Assay for the Cell‐of‐Origin Assignment of Diffuse Large B‐Cell Lymphoma

European Journal of Haematology, EarlyView.
Reassessment of the Lymph2Cx assay revealed reduced ABC representation and enrichment of the Lymph2Cx‐defined GCB category by cases classified as ABC or UNC by gold‐standard profiling, with potential implications for prognostic stratification and clinical trial interpretation.
Maria Carmela Vegliante, Grazia Gargano, Susanna Anita Pappagallo, Carla Minoia, Gian Maria Zaccaria, Giancarlo Castellano, Luisa Lorenzi, Anna Scattone, Nicoletta Del Buono, Attilio Guarini, Stefano Aldo Pileri, Sabino Ciavarella, Luigi Palla   +12 more
wiley   +1 more source